YSB Inc
Company Profile
Business description
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Contact
No. 8 Brand Street, No. 397 Xingang Middle Road
Yaoshibang Building
TIT Creative Industry Zone
Guangzhou
CHNT: +86 4001180958
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2026
Employees
6,620
Stocks News & Analysis
stocks
Weekly earnings wrap: Last week’s winners & losers
stocks
Alphabet earnings: Continued momentum on cloud and search as capital expenses set to mount
stocks
Eli Lilly earnings: Revenue increases reflect global demand for oral obesity therapies
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,954.60 | 104.20 | -1.15% |
| CAC 40 | 8,279.60 | 41.43 | 0.50% |
| DAX 40 | 24,714.42 | 223.36 | 0.91% |
| Dow JONES (US) | 49,784.77 | 876.05 | 1.79% |
| FTSE 100 | 10,375.76 | 66.54 | 0.65% |
| HKSE | 26,559.95 | 325.29 | -1.21% |
| NASDAQ | 22,865.91 | 325.33 | 1.44% |
| Nikkei 225 | 54,253.68 | 435.64 | 0.81% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,894.39 | 95.99 | 1.41% |
| S&P/ASX 200 | 8,708.80 | 96.70 | -1.10% |
| SSE Composite Index | 4,065.58 | 10.33 | -0.25% |